2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Heinz Drexel, Marco Metra et al.|European Heart Journal|2021Cited by 13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureTheresa A. McDonagh, Robert J. Mentz, Marco Metra et al.|European Heart Journal|2023Cited by 2.2k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology SocietyAlexander R. Lyon, Daniel J. Lenihan, Teresa López‐Fernández et al.|European Journal of Heart Failure|2020Cited by 767
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trialFriedrich Koehler, Karl Stangl, Kerstin Koehler et al.|The Lancet|2018Cited by 734
Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of CardiologyPetar Seferović, John J.V. McMurray, Mark C. Petrie et al.|European Journal of Heart Failure|2018Cited by 716